| 臺大學術典藏 |
2022-04-26T08:31:15Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze-Hwei; Lin, Chien-Chin; Wei, Chao-Hong; Chang, Ko-Ping; Yuan, Chang-Tsu; Tsai, Cheng-Hong; Liu, Jia-Hao; Hou, Hsin-An; Tang, Jih-Lu; WEN-CHIEN CHOU; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-04-26T08:29:09Z |
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome
|
Wang, Yu-Hung; Lin, Chien-Chin; CHI-YUAN YAO; Hsu, Chia-Lang; Tsai, Cheng-Hong; Hou, Hsin-An; WEN-CHIEN CHOU; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-04-26T08:26:49Z |
Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015
|
Hou, Hsin-An; Tzeng, Huey-En; Liu, Hung-Yi; WEN-CHIEN CHOU; Tien, Hwei-Fang; Chien, Li-Nien |
| 臺大學術典藏 |
2022-04-26T08:24:46Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien, Feng-Ming; Tsai, Cheng-Hong; Huang, Sheng-Chuan; Liu, Jia-Hau; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU; Ko, Bor-Sheng; WEN-CHIEN CHOU; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-04-26T08:21:05Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; Tien, Feng-Ming; Liu, Jia-Hau; WEN-CHIEN CHOU; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; Lin, Yun-Chu; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-04-26T08:18:46Z |
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
|
Huang, Shang-Yi; Lin, Hsiu-Hsia; MING YAO; Tang, Jih-Luh; Wu, Shang-Ju; WEN-CHIEN CHOU; SZU-CHUN HSU; Ko, Bor-Sheng; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-04-26T08:16:16Z |
Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair
|
Chen, Tsung-Chih; CHI-YUAN YAO; Chen, Yu-Ren; Yuan, Chang-Tsu; Lin, Chien-Chin; Hsu, Yueh-Chwen; Chuang, Po-Han; Kao, Chein-Jun; Li, Yi-Hung; Hou, Hsin-An; WEN-CHIEN CHOU; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-02-14T23:55:23Z |
Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair
|
Chen, Tsung Chih; CHI-YUAN YAO; Chen, Yu Ren; Yuan, Chang Tsu; CHIEN-CHIN LIN; Hsu, Yueh Chwen; Chuang, Po Han; Kao, Chein Jun; Li, Yi Hung; HSIN-AN HOU; WEN-CHIEN CHOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2022-01-25T05:32:21Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2022-01-10T08:54:12Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-12-14T23:12:05Z |
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
|
Wang, Yu Hung; HSIN-AN HOU; CHIEN-CHIN LIN; YUAN-YEH KUO; CHI-YUAN YAO; CHIA-LANG HSU; Tseng, Mei Hsuan; CHENG-HONG TSAI; Peng, Yen Ling; Kao, Chein Jun; WEN-CHIEN CHOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-11-21T23:19:44Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu Wen; Tsai, Xavier Cheng Hong; HSIN-AN HOU; Tien, Feng Ming; Liu, Jia Hau; WEN-CHIEN CHOU; BOR-SHENG KO; YU-WEN CHEN; CHIEN-CHIN LIN; Cheng, Chieh Lung; Lo, Min Yen; Lin, Yun Chu; Lu, Li Chun; SHANG-JU WU; SUNG-HSIN KUO; Hong, Ruey Long; TAI-CHUNG HUANG; MING YAO |
| 臺大學術典藏 |
2021-11-21T23:19:35Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien, Feng Ming; CHENG-HONG TSAI; Huang, Sheng Chuan; Liu, Jia Hau; Chen, Chien-Yuan; YUAN-YEH KUO; Chuang, Yi Kuang; Tseng, Mei Hsuan; Peng, Yen Ling; Liu, Ming Chih; CHIA-WEN LIU; Liao, Xiu Wen; LIANG-IN LIN; Wu, Yu Sin; Hou, Mei Fang; SHANG-JU WU; SZU-CHUN HSU; BOR-SHENG KO; WEN-CHIEN CHOU; MING YAO; HSIN-AN HOU; JIH-LUH TANG; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-10-21T23:27:14Z |
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome
|
Wang, Yu Hung; CHIEN-CHIN LIN; Yao, Chi Yuan; CHIA-LANG HSU; CHENG-HONG TSAI; HSIN-AN HOU; WEN-CHIEN CHOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-09-14T23:18:36Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze Hwei; CHIEN-CHIN LIN; Wei, Chao Hong; Chang, Ko Ping; Yuan, Chang Tsu; CHENG-HONG TSAI; Liu, Jia Hao; HSIN-AN HOU; Tang, Jih Lu; WEN-CHIEN CHOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-08-15T00:07:56Z |
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
|
SHANG-YI HUANG; Lin, Hsiu Hsia; MING YAO; JIH-LUH TANG; SHANG-JU WU; WEN-CHIEN CHOU; SZU-CHUN HSU; BOR-SHENG KO; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-07-15T05:31:45Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-07-07T04:42:35Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; Lin, Liang-In; WEN-CHIEN CHOU; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang; MING YAO |
| 臺大學術典藏 |
2021-02-05T06:29:52Z |
Hypovolemic shock and mortality after ingestion of Tripterygium wilfordii hook F.: a case report
|
Wen-Chien Chou;Wu C.-C.;Yang P.-C.;Lee Y.-T.; WEN-CHIEN CHOU; Wu C.-C.; Yang P.-C.; Lee Y.-T. |
| 臺大學術典藏 |
2021-02-05T06:29:51Z |
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
|
Huang S.-Y.I.; Chang C.-S.; Tang J.-L.; Tien H.-F.; Kuo T.-L.I.; Huang S.-F.; Yao Y.U.-T.; WEN-CHIEN CHOU; Chung C.-Y.; Wang C.-H.; Shen M.-C.; Chen Y.-C. |
| 臺大學術典藏 |
2021-02-05T06:29:51Z |
Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma: Special emphasis on the tumor response to 13-cis retinoic acid
|
Wen-Chien Chou;Su I.-J.;Tien H.-F.;Liang D.-C.;Wang C.-H.;Chang Y.-C.;Cheng A.-L.; WEN-CHIEN CHOU; Su I.-J.; Tien H.-F.; Liang D.-C.; Wang C.-H.; Chang Y.-C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-05T06:29:51Z |
Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: A high relapse rate in patients with high initial and peak white blood cell counts during all-trans-retinoic acid treatment
|
Wen-Chien Chou;Tang J.-L.;Yao M.;Liang Y.-J.;Lee F.-Y.;Lin M.-T.;Wang C.-H.;Shen M.-C.;Chen Y.-C.;Tien H.-F.; WEN-CHIEN CHOU; Tang J.-L.; Yao M.; Liang Y.-J.; Lee F.-Y.; Lin M.-T.; Wang C.-H.; Shen M.-C.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:50Z |
Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells
|
Wen-Chien Chou;Jie C.;Kenedy A.A.;Jones R.J.;Trush M.A.;Dang C.V.; WEN-CHIEN CHOU; Jie C.; Kenedy A.A.; Jones R.J.; Trush M.A.; Dang C.V. |
| 臺大學術典藏 |
2021-02-05T06:29:50Z |
Arsenic inhibition of telomerase transcription leads to genetic instability
|
Wen-Chien Chou;Hawkins A.L.;Barrett J.F.;Griffin C.A.;Dang C.V.; WEN-CHIEN CHOU; Hawkins A.L.; Barrett J.F.; Griffin C.A.; Dang C.V. |
| 臺大學術典藏 |
2021-02-05T06:29:50Z |
Clonal disease of natural killer large granular lymphocytes in Taiwan
|
WEN-CHIEN CHOU; Chiang I.-P.; Tang J.-L.; Su I.-J.; Huang S.-Y.I.; Chen Y.-C.; Liu M.-C.; Lee F.-Y.U.; Wang C.-H.; Shen M.-C.; Chuang S.-M.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:49Z |
Chromosomal abnormalities of 200 Chinese patients with non-Hodgkins's lymphoma in Taiwan: With special reference to T-cell lymphoma
|
Chen C.-Y.;Yao M.;Tang J.-L.;Tsay W.;Wang C.-C.;Wen-Chien Chou;Su I.-J.;Lee F.-Y.;Liu M.-C.;Tien H.-F.; Chen C.-Y.; Yao M.; Tang J.-L.; Tsay W.; Wang C.-C.; WEN-CHIEN CHOU; Su I.-J.; Lee F.-Y.; Liu M.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:49Z |
Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation
|
Wen-Chien Chou;Chen H.-Y.;Yu S.-L.;Cheng L.;Yang P.-C.;Dang C.V.; WEN-CHIEN CHOU; Chen H.-Y.; Yu S.-L.; Cheng L.; Yang P.-C.; Dang C.V. |
| 臺大學術典藏 |
2021-02-05T06:29:49Z |
Acute promyelocytic leukemia: Recent advances in therapy and molecular basis of response to arsenic therapies
|
Wen-Chien Chou;Dang C.V.; WEN-CHIEN CHOU; Dang C.V. |
| 臺大學術典藏 |
2021-02-05T06:29:48Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Wu S.-J.;Yao M.;Wen-Chien Chou;Tang J.-L.;Chen C.-Y.;Ko B.-S.;Huang S.-Y.;Tsay W.;Chen Y.-C.;Shen M.-C.;Wang C.-H.;Yeh Y.-C.;Tien H.-F.; Wu S.-J.; Yao M.; WEN-CHIEN CHOU; Tang J.-L.; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:48Z |
Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution
|
Wen-Chien Chou;Tang J.-L.;Lin L.-I.;Yao M.;Tsay W.;Chen C.-Y.;Wu S.-J.;Huang C.-F.;Chiou R.-J.;Tseng M.-H.;Lin D.-T.;Lin K.-H.;Chen Y.-C.;Tien H.-F.; WEN-CHIEN CHOU; Tang J.-L.; Lin L.-I.; Yao M.; Tsay W.; Chen C.-Y.; Wu S.-J.; Huang C.-F.; Chiou R.-J.; Tseng M.-H.; Lin D.-T.; Lin K.-H.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:48Z |
A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias [8]
|
Lin L.-I.;Lin T.-C.;Wen-Chien Chou;Tang J.-L.;Lin D.-T.;Tien H.-F.; Lin L.-I.; Lin T.-C.; WEN-CHIEN CHOU; Tang J.-L.; Lin D.-T.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:47Z |
Severe pulmonary complications after initial treatment with rituximab for the Asian-variant of intravascular lymphoma
|
Wu S.-J.; WEN-CHIEN CHOU; Ko B.-S.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:47Z |
Erratum: A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias (Leukemia (2007) vol. 21 (2236) 10.1038/sj.leu.2404888)
|
Lin L.-I.; Lin T.-C.; WEN-CHIEN CHOU; Tang J.-L.; Lin D.-T.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:47Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
WEN-CHIEN CHOU; Tang J.-L.; Wu S.-J.; Tsay W.; Yao M.; Huang S.-Y.; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:46Z |
Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD
|
Hou H.-A.; WEN-CHIEN CHOU; Lin L.-I.; Chen C.-Y.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:46Z |
RUNX1 gene mutation in primary myelodysplastic syndrome - The mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
|
Chen C.-Y.; Lin L.-I.; Tang J.-L.; Ko B.-S.; Tsay W.; WEN-CHIEN CHOU; Yao M.; Wu S.-J.; Tseng M.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:46Z |
Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia
|
Lee C.-Y.; Tien H.-F.; Hu C.-Y.; WEN-CHIEN CHOU; Lin L.-I. |
| 臺大學術典藏 |
2021-02-05T06:29:45Z |
Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia
|
Lee C.-Y.; Tien H.-F.; Hou H.-A.; WEN-CHIEN CHOU; Lin L.-I. |
| 臺大學術典藏 |
2021-02-05T06:29:45Z |
Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia
|
Hou H.-A.;Wen-Chien Chou;Lin L.-I.;Tang J.-L.;Tseng M.-H.;Huang C.-F.;Yao M.;Chen C.-Y.;Tsay W.;Tien H.-F.; Hou H.-A.; WEN-CHIEN CHOU; Lin L.-I.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Yao M.; Chen C.-Y.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:45Z |
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
|
Wen-Chien Chou;Chen C.-Y.;Hou H.-A.;Lin L.-I.;Tang J.-L.;Yao M.;Tsay W.;Ko B.-S.;Wu S.-J.;Huang S.-Y.;Hsu S.-C.;Chen Y.-C.;Huang Y.-N.;Tseng M.-H.;Huang C.-F.;Tien H.-F.; WEN-CHIEN CHOU; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:44Z |
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation
|
Wen-Chien Chou;Hou H.-A.;Chen C.-Y.;Tang J.-L.;Yao M.;Tsay W.;Ko B.-S.;Wu S.-J.;Huang S.-Y.;Hsu S.-C.;Chen Y.-C.;Huang Y.-N.;Chang Y.-.;Lee F.-Y.;Liu M.-C.;Liu C.-W.;Tseng M.-H.;Huang C.-F.;Tien H.-F.; WEN-CHIEN CHOU; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:44Z |
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations
|
Tang J.-L.;Hou H.-A.;Chen C.-Y.;Liu C.-Y.;Wen-Chien Chou;Tseng M.-H.;Huang C.-F.;Lee F.-Y.;Liu M.-C.;Yao M.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Wu S.-J.;Tsay W.;Chen Y.-C.;Lin L.-I.;Tien H.-F.; Tang J.-L.; Hou H.-A.; Chen C.-Y.; Liu C.-Y.; WEN-CHIEN CHOU; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Lin L.-I.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:44Z |
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival
|
Shih T.T.-F.;Hou H.-A.;Liu C.-Y.;Chen B.-B.;Tang J.-L.;Chen H.-Y.;Wei S.-Y.;Yao M.;Huang S.-Y.;Wen-Chien Chou;Hsu S.-C.;Tsay W.;Yu C.-W.;Hsu C.-Y.;Tien H.-F.;Yang P.-C.; Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y.; Yao M.; Huang S.-Y.; WEN-CHIEN CHOU; Hsu S.-C.; Tsay W.; Yu C.-W.; Hsu C.-Y.; Tien H.-F.; Yang P.-C. |
| 臺大學術典藏 |
2021-02-05T06:29:43Z |
A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutations
|
Wen-Chien Chou;Huang Y.-N.;Huang C.-F.;Tseng M.-H.;Tien H.-F.; WEN-CHIEN CHOU; Huang Y.-N.; Huang C.-F.; Tseng M.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:43Z |
Psoas abscess caused by non-typhoid salmonella in a patient with severe aplastic anemia
|
Kuo C.-C.;Ku S.-C.;Wang J.-T.;Tsai C.-W.;Wu V.-C.;Wen-Chien Chou; Kuo C.-C.; Ku S.-C.; Wang J.-T.; Tsai C.-W.; Wu V.-C.; WEN-CHIEN CHOU |
| 臺大學術典藏 |
2021-02-05T06:29:43Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Hou H.-A.;Huang T.-C.;Lin L.-I.;Liu C.-Y.;Chen C.-Y.;Wen-Chien Chou;Tang J.-L.;Tseng M.-H.;Huang C.-F.;Chiang Y.-C.;Lee F.-Y.;Liu M.-C.;Yao M.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Wu S.-J.;Tsay W.;Chen Y.-C.;Tien H.-F.; Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; WEN-CHIEN CHOU; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:42Z |
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
|
Wen-Chien Chou;Huang H.-H.;Hou H.-A.;Chen C.-Y.;Tang J.-L.;Yao M.;Tsay W.;Ko B.-S.;Wu S.-J.;Huang S.-Y.;Hsu S.-C.;Chen Y.-C.;Huang Y.-N.;Chang Y.-C.;Lee F.-Y.;Liu M.-C.;Liu C.-W.;Tseng M.-H.;Huang C.-F.;Tien H.-F.; WEN-CHIEN CHOU; Huang H.-H.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:42Z |
Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia
|
Hou H.-A.;Shih T.T.F.;Liu C.-Y.;Chen B.-B.;Tang J.-L.;Yao M.;Huang S.-Y.;Wen-Chien Chou;Hsu C.-Y.;Tien H.-F.; Hou H.-A.; Shih T.T.F.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Yao M.; Huang S.-Y.; WEN-CHIEN CHOU; Hsu C.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:41Z |
CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
|
Lin T.-C.;Hou H.-A.;Wen-Chien Chou;Ou D.-L.;Yu S.-L.;Tien H.-F.;Lin L.-I.; Lin T.-C.; Hou H.-A.; WEN-CHIEN CHOU; Ou D.-L.; Yu S.-L.; Tien H.-F.; Lin L.-I. |
| 臺大學術典藏 |
2021-02-05T06:29:41Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Wen-Chien Chou;Lei W.-C.;Ko B.-S.;Hou H.-A.;Chen C.-Y.;Tang J.-L.;Yao M.;Tsay W.;Wu S.-J.;Huang S.-Y.;Hsu S.-C.;Chen Y.-C.;Chang Y.-C.;Kuo K.-T.;Lee F.-Y.;Liu M.-C.;Liu C.-W.;Tseng M.-H.;Huang C.-F.;Tien H.-F.; WEN-CHIEN CHOU; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
